NCT04510922View on ClinicalTrials.gov

Lundbeck TOMs Orthostatic Hypotension

PHASE4CompletedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

February 11, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Orthostatic HypotensionIdiopathic Parkinson Disease

Interventions

DRUG

Droxidopa 100 MG [Northera]

droxidopa taken three times a day titrated up to a maximum of 600 mg.

Trial Locations (1)

45219

University of Cincinnati, Cincinnati

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Lundbeck LLC

INDUSTRY

lead

Alberto Espay, MD, MSc

OTHER